Peptide CDMO Services


Jiuzhou Pharma's peptides platform provides one-stop CDMO services to global clients, from preclinical pharmaceutical research to commercial production of peptide (including conjugated) drugs, as well as preclinical research of oligonucleotide drugs.

Peptide CDMO Services

Highlights

The Suzhou Production Base has a GMP peptide production workshop with a production capacity of 3 kg/batch and 70–90 kg/year.

The Raybow Production Base in Zhejiang has OEB 4 and OEB 5 GMP production workshops for highly potent drug conjugates, with a production capacity of 600 g/batch and 25–30 kg/year.

Peptide Platform Equipment

Hangzhou Laboratory

Hangzhou Laboratory

•  Synthesis reactors (3–20 L)
•  Analytical High Performance Liquid Chromatography (HPLC) System (Thermo Fisher Vanquish)
•  Preparative systems (normal phase and reverse phase) (DAC 50 – DAC 200)
•  Freeze dryers (0.18–1 m2)
•  Rigid isolators for highly potent reactions
Suzhou GMP Workshop

Suzhou GMP Workshop

•  Peptide synthesizers (5–200 L)
•  Peptide cleavage system (50 L)
•  Cyclization tanks (200–1,000 L)
•  Rotary evaporator (50 L)
•  High-pressure preparative liquid chromatography system (explosion-proof DAC 300)
•  5 m² freeze dryer (capacity: 10–3,000 g/batch)
•  Annual output of peptide products: 70-90kg/year
Taizhou High Potency Manufacturing Facility

Taizhou High Potency Manufacturing Facility

•  OEB 4 and OEB 5 production lines
•  Produces high-potency compounds in clinical and commercial phases

Oligonucleotide Platform Equipment Overview

Purification System (Sepure SDL100

Purification System (Sepure SDL100

Tangential Flow Filtration System ( inscinstech TFF)

Tangential Flow Filtration System ( inscinstech TFF)

oligonucleotide synthesizer(cytiva oligosynt)

oligonucleotide synthesizer(cytiva oligosynt)

oligonucleotide synthesizer (K&A H-8)

oligonucleotide synthesizer (K&A H-8)

Business Collaboration

Innovative Drug CDMO Services

Established Business Services

Human Resources

Join Us

Jiuzhou

LinkedIn

License

Powered by 300.cn